The neuroprotective and hypothermic effect of GYKI-52466, a non- competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model

Brain Research Bulletin

Volumn 50, Issue 3, 1999, Pages 179-186

  Gyertyán, István ^a   Gigler, Gábor ^a   Simó, Annamária ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Cerebral ischemia; GYKI 52466; Hippocampal neuronal damage; Hypothermia; Neuroprotection; Spontaneous alternation

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; CHLORPROMAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; GERBIL; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BODY TEMPERATURE; CHLORPROMAZINE; EXCITATORY AMINO ACID ANTAGONISTS; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; QUINOXALINES; RECEPTORS, AMPA; TIME FACTORS;

EID: 0032723624     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00186-0     Document Type: Article

References (54)

1. Amano M., Hasegawa M., Hasegawa T., Nabeshima T. Characteristics of transient cerebral ischemia-induced deficits on various learning and memory tasks in male mongolian gerbils. Jpn. J. Pharmacol. 63:1993;469-477.
2. Andersen M.B., Sams-Dodd F. Transient cerebral ischemia inhibits juvenile recognition in the mongolian gerbil. Pharmacol. Biochem. Behav. 56:1997;719-725.
3. Babcock A.M., Graham-Goodwin H. Importance of preoperative training and maze difficulty in task performance following hippocampal damage in the gerbil. Brain Res. Bull. 42:1997;415-419.
4. Block F., Schmitt W., Schwarz M. Pretreatment but not posttreatment with GYKI-52466 reduces functional deficits and neuronal damage after global ischemia in rats. J. Neurol. Sci. 139:1996;167-172.
5. Buchan A.M., Lesiuk H., Barnes K.A., Li H., Huang Z.-G., Smith K.E., Xue D. AMPA antagonists Do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke. 24:(suppl. 1):1993;148-152.
6. Busto R., Dietrich W.D., Globus M.Y.-T., Ginsberg M.D. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci. Lett. 101:1989;299-304.
7. Caldwell M., O'Neill M., Earley B., Leonard B. NG-nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil. Eur. J. Pharmacol. 260:1994;191-200.
8. Chandler M.J., DeLeo J., Carney J.M. An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J. Pharmacol. Methods. 14:1985;137-146.
9. Colbourne F., Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654:1994;265-272.
10. Corbett D., Evans S.J., Nurse S.M. Impaired acquisition of the Morris water-maze following global ischemic damage in the gerbil. Neuroreport. 3:1992;204-206.
11. Fraser C.M., Fisher A., Cooke M.J., Thompson I.D., Stone T.W. Purine modulation of dizocilpine effects on spontaneous alternation. Psychopharmacology. 130:1997;334-342.
12. Freund T.F., Buzsáki G., Leon A., Somogyi P. Hippocampal cell death following ischemia Effects of brain temperature and anesthesia . Ment. Neurol. 108:1990;251-260.
13. Gallyas F., Wolff J.R., Bottcher H., Zaborszky L. A reliable and sensitive method to localize terminal degeneration and lysosomes in central nervous system. Stain. Technol. 55:1980;299-306.
14. Gegelashvili G., Schousboe A. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull. 45:1998;233-238.
15. Gerhardt S.C., Boast C.A. Motor activity changes following cerebral ischemia in gerbils are correlated with the degree of neuronal degeneration in hippocampus. Behav. Neurosci. 102:1988;301-303.
16. Gill R. The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 6:1994;225-256.
17. Ginsberg M.D., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627-1642.
18. Green E.J., Dietrich W.D., Dijk F., Busto R., Markgraf C.G., McCabe P.M., Ginsberg M.D., Schneiderman N. Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 580:1992;197-204.
19. Imamura L., Ohta H., Ni X.-H., Matsumoto K., Watanabe H. Effects of transient cerebral ischemia in gerbils on working memory performance in the delayed nonmatching to position task using a T-maze. Jpn. J. Pharmacol. 57:1991;601-608.
20. Itoh J., Ukai M., Kameyama T. Dynorphine A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmacol. 234:1993;9-15.
21. Judge M.E., Sheardown M.J., Jacobsen P., Honoré T. Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil. Neurosci. Lett. 133:1991;291-294.
22. Karasawa Y., Araki H., Okuyama S., Aihara H., Otomo S. Effect of minaprine and other reference drugs on passive avoidance impairment induced by cerebral ischemia in mongolian gerbils. Jpn. J. Pharmacol. 53:1990;339-346.
23. Katoh A., Ishibashi C., Shiomi T., Takahara Y., Eigyo M. Ischemia-induced irreversible deficit of memory function in gerbils. Brain Res. 577:1992;57-63.
24. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
25. Liu, X.; Kato, H.; Itoyama, Y. Neuroprotective effect of bromocriptine against cerebral ischemia. Fifth International Symposium on Pharmacology of Cerebral Ischemia, Marburg, Germany; 1994.
26. Lodge D., Bond A., O'Neill M.J., Hicks C.A., Jones M.G. Stereoselective effects of 2,3-benzodiazepines in vivo Electrophysiology and neuroprotection studies . Neuropharmacology. 35:1996;1681-1688.
27. Maginn, M.; Kelly, J. P.; Leonard, B. E. Haloperidol increases neuronal degeneration following 5 min bilaterial carotid occlusion in the mongolian gerbil. VII International Congress of Toxicology, Seattle, Washington; 1995.
28. Maginn M., Kelly J.P., Leonard B.E. Protective effects of vanoxeamine (GBR 12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia. Pharmacol. Biochem. Behav. 56:1997;727-735.
29. Malgouris C., Bardot F., Daniel M., Pellis F., Rataud J., Uzan A., Blanchard J.-C., Laduron P.M. Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci. 9:1989;3720-3727.
30. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation A perspective on the contributions of apoptosis and necrosis . Brain Res. Bull. 46:1998;281-309.
31. Meldrum B.S. Protection againts ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
32. Meldrum B.S., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
33. Meldrum B.S., Moncada C., Lekieffre D., Arvin B., Smith S. Strategies for cerebroprotection Post-synaptic glutamate antagonism versus inhibition of ischaemia-induced glutamate release . Krieglstein J., Oberpichler-Schwenk H. Pharmacology of cerebral ischemia. 1992;115-119 Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
34. Mileson B.E., Schwartz R.D. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett. 128:1991;71-76.
35. Minamisawa H., Nordström C.H., Smith M.L., Siesjp̈ B.K. The influence of mild body and brain hypothermia on ischemic brain damage. J. Cereb. Blood Flow Metab. 10:1990;365-374.
36. Mitani A., Andou Y., Masuda S., Kataoka K. Transient forebrain ischemia of three-minute duration consistently induces severe neuronal damage in field CA1 of the hippocampus in the normothermic gerbil. Neurosci. Lett. 131:1991;171-174.
37. Nellgo̊rd B., Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;2-11.
38. Nurse S., Corbett D. Direct measurement of brain temperature during and after intraischemic hypothermia Correlation with behavioral, physiological, and histological endpoints . J. Neurosci. 14:1994;7726-7734.
39. Nurse S., Corbett D. Neuroprotection after several days of mild, drug-induced hypothermia. J. Cereb. Blood Flow Metab. 16:1996;474-480.
40. O'Neill M., Caldwell M., Earley B., Canney M., O'Halloran A., Kelly J., Leonard B.E., Junein J.-L. The σ receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischemia. Eur. J. Pharmacol. 283:1995;217-225.
41. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanaesthetized rat. Stroke. 10:1979;267-272.
42. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
43. Rossini M.M., Samarzija I. Dynamics of body temperature changes in rats induced by chlorpromazine and clozapine. Acta Pharmacol. (Zagreb). 47:1997;237-243.
44. Sala M., Leone M.P., Lampugnani P., Matturri L., Gori E. Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil. Eur. J. Pharmacol. 328:1997;143-152.
45. Schmidt-Kastner R., Hossmann K.-A. Distribution of ischemic neuronal damage in the dorsal hippocampus of rat. Acta Neuropathol. (Berl.). 76:1988;411-421.
46. Sheardown M.J., Nielsen E. Ø, Hansen A.J., Jacobsen P., Honoré T. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline A neuroprotectant for cerebral ischemia . Science. 247:1990;571-574.
47. Sheardown M.J., Suzdak P.D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24h. Eur. J. Pharmacol. 236:1993;347-353.
48. Simó, A.; Gigler, G.; Gyertyán, I. The effects of AMPA antagonist GYKI-52466 and two analogues (GYKI-53405, GYKI-53655) in global cerebral ischemia models in mice and gerbils. Sixth International Symposium on Pharmacology of Cerebral Ischemia, Marburg, Germany; 1996.
49. Smith M.L., Bendek G., Dahlgren N., Rosen I., Wieloch T., Siesjo B.K. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol. Scand. 69:1984;385-401.
50. Vizi E.S., Mike A., Tarnawa I. 2,3-Benzodiazepines (GYKI 52466 and analogs) Negative allosteric modulators of AMPA receptors . CNS Drug Rev. 2:1996;91-126.
51. Vizi E.S., Mike A., Tarnawa I. The functional study of kainate receptors - Hopes and doubts. Trends Neurosci. 20:1997;396.
52. Wang D., Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res. 533:1990;78-82.
53. Welsh F.A., Sims R.E., Harris V.A. Mild hypothermia prevents ischemic injury in gerbil hippocampus. J. Cereb. Blood Flow Metab. 10:1990;557-563.
54. Wishart T., McCrea S., Ijaz S., Shuaib A. Comparisons of repetitive- and single-insult ischaemia Effects on regional brain damage and behaviour . Neuroreport. 5:1994;1541-1544.